Denali Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.2%.

Top 25 shareholders own 84.08% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.61%	Baillie Gifford & Co.	13,763,596	R$2.2b	-1.98%	0.16%
9.2%	BlackRock, Inc.	13,174,562	R$2.1b	7.99%	0.01%
8.91%	Biogen Inc.	12,751,365	R$2.0b	0%	no data
7.9%	The Vanguard Group, Inc.	11,312,439	R$1.8b	3.14%	no data
6.86%	Wellington Management Group LLP	9,823,767	R$1.5b	18.8%	0.04%
5.02%	FMR LLC	7,191,945	R$1.1b	2,990%	0.01%
4.98%	Capital Research and Management Company	7,126,533	R$1.1b	17.8%	0.01%
3.99%	Temasek Holdings (Private) Limited	5,706,345	R$893.1m	0%	0.13%
3.33%	Crestline Investors Inc.	4,760,732	R$745.1m	-8.64%	9.59%
3.1%	State Street Global Advisors, Inc.	4,434,790	R$694.1m	-29.9%	no data
2.61%	Baker Bros. Advisors LP	3,731,695	R$584.0m	0%	0.93%
2.08%	Geode Capital Management, LLC	2,982,538	R$466.8m	8.08%	0.01%
1.7%	UBS Asset Management AG	2,433,939	R$380.9m	136%	0.01%
1.69%	Marshall Wace LLP	2,418,833	R$378.6m	12.7%	0.1%
1.58%	T. Rowe Price Group, Inc.	2,255,470	R$353.0m	7.75%	0.01%
1.57%	Ryan Watts	2,241,211	R$350.8m	0.12%	no data
1.47%	Marc Tessier-Lavigne	2,111,441	R$330.5m	0.2%	no data
1.41%	AllianceBernstein L.P.	2,018,534	R$315.9m	1,370%	0.02%
1.4%	Camber Capital Management LP	2,000,000	R$313.0m	33.3%	2.07%
1.07%	BNY Asset Management	1,525,754	R$238.8m	-13.5%	0.01%
1.06%	Credit Suisse Asset Management (Switzerland) Ltd.	1,519,295	R$237.8m	0%	0.03%
0.99%	Dimensional Fund Advisors LP	1,417,472	R$221.8m	6.34%	0.01%
0.91%	Casdin Capital, LLC	1,300,000	R$203.5m	0%	2.27%
0.85%	Citadel Advisors LLC	1,218,698	R$190.7m	-10.7%	0.03%
0.8%	Yiheng Capital Management, L.P.	1,150,684	R$180.1m	0%	3.26%